Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia

Hereditary ataxia and spastic paraplegia are heterogeneous monogenic neurodegenerative disorders. To date, a large number of individuals with such disorders remain undiagnosed. Here, we have assessed molecular diagnosis by gene panel sequencing in 105 early and late-onset hereditary ataxia and spastic paraplegia probands, in whom extensive previous investigations had failed to identify the genetic cause of disease. Pathogenic and likely-pathogenic variants were identified in 20 probands (19%) and variants of uncertain significance in ten probands (10%). Together these accounted for 30 probands (29%) and involved 18 different genes. Among several interesting findings, dominantly inherited KIF1A variants, p.(Val8Met) and p.(Ile27Thr) segregated in two independent families, both presenting with a pure spastic paraplegia phenotype. Two homozygous missense variants, p.(Gly4230Ser) and p.(Leu4221Val) were found in SACS in one consanguineous family, presenting with spastic ataxia and isolated cerebellar atrophy. The average disease duration in probands with pathogenic and likely-pathogenic variants was 31 years, ranging from 4 to 51 years. In conclusion, this study confirmed and expanded the clinical phenotypes associated with known disease genes. The results demonstrate that gene panel sequencing and similar sequencing approaches can serve as efficient diagnostic tools for different heterogeneous disorders. Early use of such strategies may help to reduce both costs and time of the diagnostic process.

[1]  A. Stray-Pedersen,et al.  Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. , 2009, Brain : a journal of neurology.

[2]  Joshua L. Deignan,et al.  Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. , 2014, JAMA neurology.

[3]  L. Vissers,et al.  Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.

[4]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[5]  P. Bergh,et al.  Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome , 2004, Nature Genetics.

[6]  F. Santorelli,et al.  Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms , 2014, Experimental Neurology.

[7]  J. Fink.  Hereditary Spastic Paraplegia: Clinical Principles and Genetic Advances , 2014, Seminars in Neurology.

[8]  D. Misceo,et al.  Spastic Paraplegia Type 7 Is Associated with Multiple Mitochondrial DNA Deletions , 2014, PloS one.

[9]  A. Durr,et al.  New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix–Saguenay , 2015, Annals of neurology.

[10]  N. Matsumoto,et al.  Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood , 2013, neurogenetics.

[11]  P. Tsai,et al.  Mutations in KCND3 cause spinocerebellar ataxia type 22 , 2012, Annals of neurology.

[12]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[13]  S. Kirker,et al.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing , 2014, Journal of Neurology.

[14]  J. Koht,et al.  A founder mutation p.H701P identified as a major cause of SPG7 in Norway , 2016, European journal of neurology.

[15]  M. Burmeister,et al.  Genes and Genetic Testing in Hereditary Ataxias , 2014, Genes.

[16]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[17]  E. Storey.  Genetic Cerebellar Ataxias , 2014, Seminars in Neurology.

[18]  Christian Gilissen,et al.  Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.

[19]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[20]  V. Álvarez,et al.  SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V , 2013, Clinical genetics.

[21]  B. Fernandez,et al.  The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists , 2015, Journal of Medical Genetics.

[22]  N. Bresolin,et al.  A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia , 2008, Human mutation.

[23]  M. Mattingsdal,et al.  Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia , 2007, European journal of neurology.

[24]  Pask Ea,et al.  HOMOSEXUALITY AS A CRIME. , 1965 .

[25]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[26]  Alexandra Durr,et al.  Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond , 2010, The Lancet Neurology.

[27]  C. Sue,et al.  Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia , 2013, Journal of Neurology.

[28]  C. Espinós,et al.  Genetics and pathogenesis of inherited ataxias and spastic paraplegias. , 2009, Advances in experimental medicine and biology.

[29]  Jiannis Ragoussis,et al.  Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model , 2013, Brain : a journal of neurology.

[30]  C. Alexander Valencia,et al.  Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel , 2013, PloS one.

[31]  C. Gilissen,et al.  Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene–disease associations and unanticipated rare disorders , 2016, European Journal of Human Genetics.

[32]  C. Marshall,et al.  Exome Sequencing as a Diagnostic Tool for Pediatric-Onset Ataxia , 2013, Human mutation.

[33]  A. Al-Chalabi,et al.  Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis , 2015, Neurobiology of Aging.

[34]  J. Burgunder,et al.  EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias , 2010, European journal of neurology.

[35]  V. Ramesh,et al.  Exome sequencing in undiagnosed inherited and sporadic ataxias , 2014, Brain : a journal of neurology.

[36]  C. Ross,et al.  De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome , 2015, European Journal of Human Genetics.

[37]  Eunjoon Kim,et al.  Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia , 2015, European Journal of Human Genetics.

[38]  A. Durr,et al.  Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10 , 2009, Human mutation.

[39]  Hereditary Spastic Paraplegia , 1996, Neurology.

[40]  A. Singleton,et al.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.

[41]  J. Dopazo,et al.  Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy. , 2016, The Journal of molecular diagnostics : JMD.

[42]  J. Schulz,et al.  Diagnosis and treatment of Friedreich ataxia: a European perspective , 2009, Nature Reviews Neurology.

[43]  Avni Santani,et al.  Actionable exomic incidental findings in 6503 participants: challenges of variant classification , 2015, Genome research.

[44]  J. Haines,et al.  Hereditary Spastic Paraplegia , 1996, Neurology.

[45]  Yaniv Erlich,et al.  Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. , 2011, Genome research.

[46]  M. Toft,et al.  Effective Variant Detection by Targeted Deep Sequencing of DNA Pools: An Example from Parkinson's Disease , 2014, Annals of human genetics.

[47]  Euan A Ashley,et al.  Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.